RNA Toxicity and Muscle Regeneration
RNA 毒性和肌肉再生
基本信息
- 批准号:9252112
- 负责人:
- 金额:$ 39.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-20 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAdultAffectAntibodiesAntisense OligonucleotidesCaliberCell CountCell Culture TechniquesCell NucleusCell physiologyCellsChildCollaborationsDefectDirect Lytic FactorsEmbryoEventFamilyFatigueGenesGoalsGrantHand StrengthHistopathologyImmunofluorescence ImmunologicKnockout MiceKnowledgeMaintenanceMeasuresMediator of activation proteinModelingMorbidity - disease rateMusMuscleMuscle FatigueMuscle WeaknessMuscle functionMuscle satellite cellMuscular AtrophyMuscular DystrophiesMyoblastsMyogeninMyotoniaMyotonic DystrophyNatural regenerationPatient-Focused OutcomesPatientsPharmacologic SubstanceProcessProteinsQuality of lifeRNARNA SplicingRNA-Binding ProteinsRegenerative responseReportingReserve CellRoleSkeletal MuscleSymptomsTamoxifenTechniquesTestingTherapeuticTherapeutic EffectTimeTomatoesToxic effectTranscriptTransgenesTranslatingWorkadverse outcomeexperimental studyimprovedin vivomouse modelmuscle regenerationmutantnovelnovel therapeuticsoverexpressionreceptorregenerativerepairedresponsesatellite cellself-renewalsuccesstargeted treatmenttherapy developmentwasting
项目摘要
Project Summary:
Myotonic dystrophy (DM1) is the most common form of muscular dystrophy in adults and children. Though
there are a variety of other multi-systemic effects, DM1 is mainly characterized by myotonia and progressive
muscle wasting. Muscle weakness, wasting, and fatigue have also been reported as the most impactful
adverse outcomes by patients. RNA splicing defects have been identified as key effects of the toxic RNA
produced in DM1 patients, and using myoblast cells from mice and DM1 patients, we and others have
previously demonstrated the deleterious effects of the toxic RNA on myogenic differentiation. But little is
known about the regenerative process in DM1 or the effects of RNA toxicity on this. Addressing this key issue
is hampered without a model in which we can develop a thorough understanding of the effects of RNA toxicity
on muscle regeneration and one in which to test therapies targeting this process. Satellite cells are key cellular
mediators of muscle regeneration in response to damage. Here, we have developed the first RNA toxicity
mouse model with demonstrated expression of the toxic RNA in satellite cells. We will use this model to
characterize the effects of RNA toxicity on satellite cells and muscle regeneration. We will also study the
expression of various key proteins implicated in DM1 such as MBNL1 and CUGBP1 in satellite cells, especially
in response to damage. We will also use this model to study the effects of therapeutics on satellite cell
function in RNA toxicity. Our goal is to understand the role of RNA toxicity in the process of muscle
regeneration in order to provide a platform for developing therapies to treat muscular dystrophy in DM1.
.
项目概要:
强直性肌营养不良 (DM1) 是成人和儿童最常见的肌营养不良形式。尽管
还有多种其他多系统效应,DM1主要表现为肌强直和进行性
肌肉萎缩。据报道,肌肉无力、消瘦和疲劳也是最有影响的。
患者的不良后果。 RNA 剪接缺陷已被确定为有毒 RNA 的关键影响
我们和其他人使用来自小鼠和 DM1 患者的成肌细胞,在 DM1 患者中产生
先前证明了有毒RNA对肌原性分化的有害影响。但很少是
了解 DM1 的再生过程或 RNA 毒性对此的影响。解决这个关键问题
如果没有一个模型可以让我们全面了解 RNA 毒性的影响,那么研究就会受到阻碍
关于肌肉再生的研究,以及测试针对这一过程的疗法的研究。卫星细胞是关键的细胞
响应损伤的肌肉再生介质。在这里,我们开发了第一个 RNA 毒性
小鼠模型已证实卫星细胞中有毒 RNA 的表达。我们将使用这个模型来
表征 RNA 毒性对卫星细胞和肌肉再生的影响。我们还将研究
卫星细胞中与 DM1 相关的各种关键蛋白(例如 MBNL1 和 CUGBP1)的表达,尤其是
以应对损坏。我们还将使用该模型来研究治疗对卫星细胞的影响
在RNA毒性中发挥作用。我们的目标是了解 RNA 毒性在肌肉生长过程中的作用
再生,以便为开发治疗 DM1 型肌营养不良症的疗法提供平台。
。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mani Subramaniam Mahadevan其他文献
Mani Subramaniam Mahadevan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mani Subramaniam Mahadevan', 18)}}的其他基金
The role of TGFβs and cFAPs in Cardiac Pathology from RNA Toxicity
TGFβ 和 cFAP 在 RNA 毒性心脏病理学中的作用
- 批准号:
10717904 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Inducible Transgenic Mouse Model of RNA Toxicity
RNA毒性诱导转基因小鼠模型
- 批准号:
7483165 - 财政年份:2005
- 资助金额:
$ 39.28万 - 项目类别:
Inducible Transgenic Mouse Model of RNA Toxicity
RNA毒性诱导转基因小鼠模型
- 批准号:
6959625 - 财政年份:2005
- 资助金额:
$ 39.28万 - 项目类别:
Inducible Transgenic Mouse Model of RNA Toxicity
RNA毒性诱导转基因小鼠模型
- 批准号:
7277768 - 财政年份:2005
- 资助金额:
$ 39.28万 - 项目类别:
Inducible Transgenic Mouse Model of RNA Toxicity
RNA毒性诱导转基因小鼠模型
- 批准号:
7116873 - 财政年份:2005
- 资助金额:
$ 39.28万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别: